Heranba Industries profit and loss

Latest FY26

Revenue: ₹1,595cr+13.1% on FY25
EBITDA: ₹69.2cr−29.3% on FY25
Net profit: −₹77.6cr₹2.3 cr in FY25
EPS: −₹19.10₹0.77 in FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Expenses
	1,526	1,595	1,410	1,257	1,319	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	1.0	7.9	7.6	13.8	12.2
	1,527	1,603	1,417	1,271	1,331
	1,064	1,161	968	827	908
	77.6	51.6	7.8	16.6	7.3
	−127	−111	−30.9	23.4	−33.3
	118	116	105	85.4	67.1
	51.4	50.0	30.8	12.4	7.9
	98.7	98.1	56.6	26.1	22.7
	307	309	262	228	214
	1,589	1,674	1,399	1,219	1,193
	87.1	69.2	97.9	76.9	156
	−11.6	−28.9	41.3	50.8	133
Profit
	−62.0	−71.0	18.1	52.2	138
	−62.0	−71.0	18.1	52.2	138
	13.5	18.2	18.8	28.5	38.9
	1.4	−11.7	−2.9	−10.7	−5.7
	14.9	6.6	15.8	17.7	33.2
	−76.9	−77.6	2.3	34.5	104
	−76.9	−77.6	2.3	34.5	104
	1.9	1.4	0.0	0.0	0.2
	−75.0	−76.2	2.3	34.5	105
	−75.4	−76.4	3.1	34.9	104
	−1.5	−1.1	−0.8	0.4	0.0
Per share
	−₹18.84	−₹19.10	₹0.77	₹8.72	₹26.08
	−₹18.84	−₹19.10	₹0.77	₹8.72	₹26.08
Other comprehensive income — detail
	1.9	1.4	0.0	—	—
	1.8	1.3	0.0	0.0	0.1
	—	0.1	—	—	0.1
	—	−75.1	2.7	34.9	105
	—	−1.1	−0.9	−0.4	0.0
Per share — as-filed variants
	−₹18.84	−₹19.10	₹0.77	₹8.72	₹26.08
	−₹18.84	−₹19.10	₹0.77	₹8.72	₹26.08
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	512	494	465	390	437
	33.5%	31.0%	33.0%	31.1%	33.1%
Adjusted (ex-exceptional items) — derived
	−62.0	−71.0	18.1	52.2	138
	−76.9	−77.6	2.3	34.5	104
	−₹18.84	−₹19.10	₹0.77	₹8.72	₹26.08

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

HERANBA₹146.45

Heranba Industries Limited

· Chemicals

Annual Quarterly₹ CrorePeersADVANCE BESTAGRO DHARMAJ IGCL ASTEC PUNJABCHEM MOL IPLMcap ₹586 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Revenue from Operations	1,318.8	1,257.1	1,409.7	1,595.0	1,525.8
Other Income	12.2	13.8	7.6	7.9	1.0
Total Income	1,331.0	1,270.9	1,417.3	1,602.9	1,526.8
Expenses
+ Cost of Materials Consumed	908.0	826.8	967.9	1,160.7	1,063.5
+ Purchases of Stock-in-Trade	7.3	16.6	7.8	51.6	77.6
+ Changes in Inventories	-33.3	23.4	-30.9	-111.4	-126.9
+ Employee Benefit Expense	67.1	85.4	105.1	116.2	117.8
+ Finance Costs	7.9	12.4	30.8	50.0	51.4
+ Depreciation & Amortisation	22.7	26.1	56.6	98.1	98.7
+ Other Expenses	213.8	228.0	261.9	308.6	306.7
Total Expenses	1,193.5	1,218.7	1,399.3	1,673.9	1,588.8
EBITDA	156.0	76.9	97.9	69.2	87.1
EBIT	133.3	50.8	41.3	-28.9	-11.6
Profit
PBT before Exceptional Items	137.6	52.2	18.1	-71.0	-62.0
Pretax Income	137.6	52.2	18.1	-71.0	-62.0
+ Current Tax	38.9	28.5	18.8	18.2	13.5
+ Deferred Tax	-5.7	-10.7	-2.9	-11.7	1.4
Tax Expense	33.2	17.7	15.8	6.6	14.9
Net Income	104.4	34.5	2.3	-77.6	-76.9
+ Net Income — Continuing Ops	104.4	34.5	2.3	-77.6	-76.9
+ Other Comprehensive Income	0.2	0.0	0.0	1.4	1.9
Total Comprehensive Income	104.6	34.5	2.3	-76.2	-75.0
Net Income to Common	104.4	34.9	3.1	-76.4	-75.4
Minority Interest	0.0	0.4	-0.8	-1.1	-1.5
Per Share
Basic EPS	26.08	8.72	0.77	-19.10	-18.84
Diluted EPS	26.08	8.72	0.77	-19.10	-18.84
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	0.0	1.4	1.9
+ Items NOT to be Reclassified to P&L	0.1	0.0	0.0	1.3	1.8
+ Items to be Reclassified to P&L	0.1	—	—	0.1	—
Comprehensive Income — Owners of Parent	104.6	34.9	2.7	-75.1	—
Comprehensive Income — Non-controlling Interests	0.0	-0.4	-0.9	-1.1	—
Per Share — as-filed variants
Basic EPS — Continuing Operations	26.08	8.72	0.77	-19.10	-18.84
Diluted EPS — Continuing Operations	26.08	8.72	0.77	-19.10	-18.84
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	436.9	390.3	464.9	494.0	511.5
Gross Margin %	33.12	31.05	32.98	30.97	33.53
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	137.6	52.2	18.1	-71.0	-62.0
Net Income Adj (tax-effected)	104.4	34.5	2.3	-77.6	-76.9
EPS Adj	26.08	8.72	0.77	-19.10	-18.84
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00	10.00
Paid Up Equity Capital	40.1	40.0	40.0	40.0	40.0

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.